Understanding Cancer from a Systems Biology Point of View
From Observation to Theory and Back
- 1st Edition - February 7, 2018
- Latest edition
- Author: Irina Kareva
- Language: English
Understanding Cancer from a Systems Biology Point of View: From Observation to Theory and Back starts with a basic question, why do we sometimes observe accelerated metastati… Read more
Early spring sale
Nurture your knowledge
Grow your expertise with up to 25% off trusted resources.
Description
Description
Understanding Cancer from a Systems Biology Point of View: From Observation to Theory and Back starts with a basic question, why do we sometimes observe accelerated metastatic growth after resection of primary tumors? Next, it helps readers understand the systemic nature of cancer and how it affects treatment approaches and decisions. The book puts together aspects of cancer that many readers have most likely never combined, using unfamiliar, novel methods. It is a valuable resource for cancer researchers, cancer biologists, mathematicians and members of the biomedical field who are interested in applying systems biology methodologies for understanding and treating cancer.
Key features
Key features
- Explains the systemic nature of cancer and how it affects decisions on treatment
- Brings a variety of methods together, showing, in detail, the logical approach to finding answers to complex questions
- Discusses the theoretical underpinnings of cancer as a systemic disease, providing the reader with valuable information on applicable cases
Readership
Readership
Understanding the systemic nature of cancer and how that affects decisions made with regard to approach to treatment
Table of contents
Table of contents
1. Introduction2. Tumor dormancy3. Cancer immunoediting: a process driven by metabolic competition as a predator-prey-shared resource type model4. Escape from tumor dormancy and time to angiogenic switch as mitigated by tumor- induced stimulation of stroma5. Angiogenesis regulators as a possible key to accelerated growth of secondary tumors following primary tumor resection6. A combination of immune checkpoint inhibition with metronomic chemotherapy as a way of targeting therapy-resistant cancer cells7. Summary and conclusions
Product details
Product details
- Edition: 1
- Latest edition
- Published: February 8, 2018
- Language: English
About the author
About the author
IK